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Abstract 
Background: Dengue infection, a major public 
health problem, affects all body systems including 
hepatobiliary system that can be assessed by 
measuring serum alanine aminotransferase (ALT) 
levels. The objective of this study was to compare 
the extent of hepatic involvement in the patients of 
dengue fever (DF) with that of the patients of 
dengue haemorrhagic fever (DHF) by comparing 
mean ALT levels and degree of rise in serum ALT 
levels in patients of both groups, DF and DHF. 
Methods: A comparative analytical study was 
carried out at Department of Infectious Diseases, 
Holy Family Hospital from September 2016 to 
December 2016. A total of 184 seropositive dengue 
patients were taken using non-randomized 
consecutive sampling technique; 92 patients having 
DF and 92 patients having DHF. Blood samples for 
ALT levels were taken within 24 hours of diagnosis 
of DF and DHF. SPSS version 22 was used to analyse 
the data. Mann-Whitney U test was used to compare 
the mean ALT levels and Chi-Square test at 5% 
significance level was applied to compare the degree 
of rise in serum ALT levels in both groups.  
Results: In this comparative analytical study, 184(42 
females and 142males) seropositive dengue patients 
were included. The mean serum ALT level in 
patients of DF was 85.43(±58.685) while mean ALT 
levels in patients of DHF was 167.76(±155.656), 
(p=0.00).The degree of serum ALT rise in DHF 
patients was significantly higher than that of DF 
patients (p=0.00). 
Conclusion: The extent of hepatic damage is more 
in dengue haemorrhagic fever as compared to 
uncomplicated dengue fever. 
Keywords: dengue fever, dengue haemorrhagic 
fever, alanine aminotransferase 
Introduction 
Dengue fever also known as break bone fever, is a 
major public health problem in Pakistan.1,2 It is an 
arthropod borne viral disease transmitted by 
mosquitoes mainly of the species Aedes aegypti.3 
Dengue fever has very wide clinical spectrum 
including asymptomatic dengue fever,  acute febrile 
illness, dengue fever, DF, (seropositive patients with 
fever and had other constitutional symptoms) , dengue 
haemorrhagic fever, DHF, (Haemorrhagic 
manifestation, thrombocytopenia and plasma leakage 
or hemoconcentration) and dengue shock syndrome, 
DSS ( symptoms of DHF, narrow pulse pressure of less 
than 20 mm Hg and cold extremities ).4,5,6 
Dengue virus has four serotypes namely DEN-1, DEN-
2, DEN-3 and DEN-4.7 The patients acquires lifelong 
immunity against the causative serotype but if the 
same patient is affected by another serotype of dengue 
virus, chances to develop complicated disease 
increases i.e. DHF and DSS.8 
Dengue infection affects the function of multiple 
organs including liver, so it is necessary to assess the 
integrity of liver parenchyma in dengue patients for 
appropriate and timely interventions.7 Serum alanine 
aminotransferase (ALT) levels is an indicator of liver 
parenchyma function. Studies suggest that serum ALT 
levels rise in proportionate to liver injury.9 A patient 
with hepatic involvement in dengue infection may 
develop jaundice (hyperbilirubinemia), hepatomegaly, 
GI hemorrhage and biochemical changes i.e., increase 
in serum aminotransferases. 
 The purpose of this study was to compare the extent 
of hepatic involvement in patients of DF with that of 
the patients of DHF by comparing mean ALT levels 
and degree of rise in serum ALT levels in patients of 
both groups, DF and DHF. 
 
Materials And Methods 
This comparative analytical study was conducted at 
department of infectious diseases, Holy Family 
Hospital, Rawalpindi from September 2016 to 
December 2016.The Hospital is a tertiary care affiliated 
with Rawalpindi Medical College, Rawalpindi, 
Pakistan. 
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 A total of 184 seropositive dengue patients were 
studied using non-randomized consecutive technique; 
92 patients having dengue fever and 92 having dengue 
haemorrhagic fever.  
Patients were divided according to the WHO criteria, 
DF, DHF which includes dengue shock syndrome as 
well. The patients were divided according to their ALT 
levels into Grade A (normal serum ALT level), Grade 
B (mildly raised serum ALT), Grade C (moderately 
raised serum ALT) and Grade D (severely raised 
serum ALT). 
ELISA technique for IgM, IgG and NS-1 was used to 
confirm the infectious status of the patients. Patients 
having any co-morbidity involving liver parenchyma 
were excluded. 2 ml blood was drawn from median 
cubital vein after cleansing the area with spirit swab 
using a 5 cc 21 gauge syringe, within 24hrs of 
diagnosis of DF and DHF. Blood samples were then 
sent to laboratory for estimation of serum ALT levels 
using Beckman counter AU 480.  
Statistical Package for Social Sciences (SPSS) version 22 
was used to enter and analyse the data. Mann Whitney 
U test was used to compare mean serum ALT levels 
and Chi Square Test at 5% significance level and 
keeping confidence interval at 95% was applied to 
compare the degree of rise in serum ALT levels in both 
groups. P value less than 0.05 was considered 
significant. 
The ethical approval was granted by the institutional 
research forum of Rawalpindi Medical College, 
Rawalpindi. 
 
Results 
Out of 184 patients included in our study, 142 (77.2%) 
were males and 42 (22.8%) were females.  
The disease was more prevalent among males with 
male to female ratio of 3.4: 1.  
The mean age of affected population was 32.74±14.74 
years. 
The mean serum ALT level was significantly higher in 
the patients having dengue haemorrhagic fever as 
compared to the patients having dengue fever.Mean 
serum ALT levels in most of the patients with dengue 
fever lies in category of mildly raised ALT levels and 
that of dengue haemorrhagic fever lies in category of 
moderately raised ALT levels. (Table I) 
When these levels were compared using Mann 
Whitney U test, very highly significant (p=0.000) 
results were obtained. 
After a dengue viral infection, mildly raised serum 
ALT levels is seen in majority of the patients, it is 
seconded by moderately raised serum ALT levels 
which is more commonly found among patients of 
DHF. Severely raised serum ALT levels were, 
however, found only among patients of dengue 
haemorrhagic fever. (Table II) 
 
TABLE I: Mean Serum ALT levels in DF and DHF 
          Diagnosis Mean Serum ALT 
Level 
(U/l) 
Dengue Fever 85.43 ± 58.685 
Dengue Hemorrhagic Fever 167.76 ± 155.656 
  
TABLE II: Distribution of Patients in DF and DHF in 
relation to serum ALT levels 
ALT Level GRADE Serum  
ALT Level 
Dengue 
Fever 
N=92(100%) 
Dengue 
Hemorrhagic 
Fever 
N=92(100%) 
Normal ALT 
Level 
Grade A < 43U/l 30(32.6%)  8(8.7%) 
Mildly raised 
ALT level 
Grade B 
 
44-129 U/l  40(43.5%) 44(47.8%) 
Moderately 
raised ALT 
level 
Grade C 130-430 U/l 22(23.9%)  32(34.8) 
Severely 
raised ALT 
level 
Grade D > 430 U/l  -  8(8.7%) 
 
When these levels were compared using Pearson Chi-
Square test, very highly significant (x2 =22.779, 
p=0.000) results were obtained. 
Degree of serum ALT rise was higher in DHF patients 
as compared to that of DF patients. (Figure I) 
difference was observed (p=0.00).  
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FIGURE 1: Relation between number of patients and 
degree of rise in serum ALT 
Severity of the disease is more among male population 
as compared to females. Severely raised ALT levels 
were only found among the male patients while there 
was a considerable difference in other categories with 
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raised serum ALT levels being more common among 
male patients. (Figure II) 
When ALT level ranges in patients of DF and DHF 
were compared, statistically highly significant  
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FIGURE II: Gender distribution and degree of serum 
ALT changes 
 
Discussion 
Dengue Fever is endemic in 125 countries of the 
world.10,11 It is the most common viral infection 
affecting humans in this point of time.12 The disease is 
more prevalent in tropics and subtropics especially in 
south East Asia.13,14 In Pakistan first major outbreak of 
dengue infection was reported in 1994, followed by 
large number of cases reporting every year.15 WHO 
has set a criteria and categorized the infection in three 
subgroups namely dengue fever, dengue 
haemorrhagic fever and dengue shock syndrome. 
The involvement of liver in dengue viral infection is 
not uncommon.16 The severity of the dengue infection 
is proportional to liver damage and hence a positive 
predictor of progression of DF to DHF.17 It is widely 
accepted that liver damage and rise in serum ALT 
levels is significantly higher among patients of DHF 
and DSS as compared to patients with DF.18,19 While 
these studies and our study show a significant 
difference in serum ALT level of patients having DF 
and DHF some studies show that there is no 
significant difference.20,21 
It is proposed that an increase in serum ALT levels in 
dengue infection is because of the underlying hepatic 
inflammation and direct attack of virus on the 
hepatocytes, this inflammation releases the hepatic 
enzymes in blood.22,23 
Hepatic involvement in dengue fever prolongs the 
disease process and leads to the complications of the 
disease.19 Hepatic involvement in dengue fever is of 
significant importance because it can lead to fulminant 
hepatitis, hepatic encephalopathy, renal failure and 
gastrointestinal bleeding. All these combined may be 
fatal and may lead to death of the patient.17,21,24 
The mean age of patients was 32.74±14.74.There was a 
greater incidence of dengue infection among male 
gender with a male to female ratio of 3.4:1, age and 
gender distribution were in accordance to the 
previously conducted studies. The probable reason of 
high incidence among male population is more 
exposure to outdoor environment, hence more 
exposure to mosquitoes.25 Similar results have not 
been seen in studies conducted in India, Sri Lanka and 
Thailand.26,27,28 
In our study the mean serum ALT levels in patients of 
dengue haemorrhagic fever was significantly higher as 
compared to patients having uncomplicated dengue 
fever. The mean serum ALT levels in patients of 
dengue fever and dengue haemorrhagic fever 
including dengue shock syndrome is 85.43 ± 58.685 
and 167.76 ± 155.656 respectively. These results are in 
accordance with study done by Chhina RS.29 
It was seen that indeed majority of patients with 
dengue infection have either mildly raised or 
moderately raised serum ALT levels while other 
patients have normal or severely raised ALT levels, 
this is in accordance to the studies already 
conducted.29 It was seen that only the patients with 
DHF had severely raised serum ALT levels but the 
distribution in mildly raised serum ALTs was 
comparable in both groups. Moderately raised serum 
ALT levels were found to be more among the DHF 
group. 
Hence, it is proposed that sero-positive dengue 
patients having raised serum ALT levels dealt with 
more care at the time of admission to hospital, so that 
complications of disease could be reduced. 
 
Conclusion 
This study concluded that extent of hepatic damage is 
more in dengue haemorrhagic fever as compared to 
uncomplicated dengue fever. 
Our study suggests that  
1) Serum ALT levels of seropositive dengue patients 
may serve as an indicator of disease progression in 
dengue infection during hospital stay. 
2) Serum ALT levels at time of admission to hospital 
may serve as an indicator of disease severity in dengue 
infection. 
Our study was based on serum alanine 
aminotransferase but other liver function tests such as 
serum aspartate aminotransferase, serum alkaline 
phosphatase and serum bilirubin may also be used to 
broaden the scope of the study. 
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